A vaccine study used SARS-CoV-2 Spike protein administered repeatedly, and in another study, a high dose of antigen in a tuberculosis vaccine trial was found detrimental for protection, mediated by T cell exhaustion and immune tolerance (14, 15). Here, CHMP5 is linked to tuberculosis.